Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
dementia   save search
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
BIVI | News | $0.497 1.76% 240K twitter stocktwits trandingview |
Health Technology
 | | O: 5.49% H: 2.0% C: -2.0%
ne3107
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
CLPT | $5.37 -0.37% 10K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
avb-101 first dementia for trial
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-15 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M twitter stocktwits trandingview |
Health Technology
 | | O: -0.04% H: 0.0% C: 0.0%
avb-101 first dementia for trial
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
BTAI | $2.715 6.47% 180K twitter stocktwits trandingview |
Health Technology
 | | O: 0.96% H: 1.9% C: 0.0%
bxcl501 alzheimer’s dementia for trial therapeutics
BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
Published: 2024-03-15 (Crawled : 11:00) - globenewswire.com
BTAI | $2.715 6.47% 180K twitter stocktwits trandingview |
Health Technology
 | | O: -1.74% H: 2.13% C: -4.96%
patent grant therapeutics
Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 Conference
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
COYA | News | $8.54 1.19% 5.8K twitter stocktwits trandingview |
| | O: 1.99% H: 2.47% C: -0.62%
conference neuroinflammatory biomarker dementia therapeutics
Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 Conference
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
COYA | News | $8.54 1.19% 5.8K twitter stocktwits trandingview |
| | O: 0.0% H: 1.1% C: -5.86%
conference cell dementia system therapeutics
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2024-02-07 (Crawled : 12:00) - globenewswire.com
GSK | $39.685 1.06% 380K twitter stocktwits trandingview |
Health Technology
 | | O: 0.43% H: 0.67% C: 0.21%
ALEC | $5.165 1.47% 51K twitter stocktwits trandingview |
Health Technology
 | | O: 2.15% H: 5.51% C: 3.73%
fda dementia designation grants therapy
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
Published: 2023-12-13 (Crawled : 12:00) - globenewswire.com
CNTG | $0.461 14K twitter stocktwits trandingview |
Commercial Services
 | | O: -4.72% H: 5.79% C: 3.31%
genetic dementia milestone
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
Published: 2023-12-12 (Crawled : 12:00) - globenewswire.com
ATHA | $2.14 3.88% 68K twitter stocktwits trandingview |
Health Technology
 | | O: -2.93% H: 10.55% C: 6.53%
fosgonimeton pharma disease parkinson's treatment dementia trial results
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
Published: 2023-11-06 (Crawled : 18:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M twitter stocktwits trandingview |
Health Technology
 | | O: 0.57% H: 0.0% C: 0.0%
avb-101 fda treatment dementia clearance designation
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2023-10-27 (Crawled : 11:00) - globenewswire.com
GSK | $39.685 1.06% 380K twitter stocktwits trandingview |
Health Technology
 | | O: -0.7% H: 0.0% C: -2.46%
ALEC | $5.165 1.47% 51K twitter stocktwits trandingview |
Health Technology
 | | O: 0.76% H: 0.38% C: -3.57%
dementia trial
Therini Bio Announces Interim Results from the Phase 1 Trial of THN391 for the Potential Treatment of Dementia
Published: 2023-10-24 (Crawled : 14:00) - biospace.com/
LLY | $731.1 -1.99% 1M twitter stocktwits trandingview |
Health Technology
 | | O: -0.84% H: 0.0% C: 0.0%
SNY | News | $46.34 2.09% 620K twitter stocktwits trandingview |
Health Technology
 | | O: 0.77% H: 0.0% C: 0.0%
thn391 treatment dementia trial potential results
CervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major Dementias
Published: 2023-10-24 (Crawled : 11:00) - prnewswire.com
FUSN | $21.22 -0.14% 77K twitter stocktwits trandingview |
Health Technology
 | | O: -3.55% H: 21.58% C: 5.0%
potential therapy
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
Published: 2023-10-10 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M twitter stocktwits trandingview |
Health Technology
 | | O: 0.67% H: 0.56% C: -0.01%
avb-101 dementia
Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia
Published: 2023-09-11 (Crawled : 15:00) - biospace.com/
TSOI | $0.0007 33M twitter stocktwits trandingview |
Manufacturing
 | | O: -7.69% H: 16.67% C: 8.33%
international cell dementia solutions therapy
Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon
Published: 2023-07-26 (Crawled : 21:00) - prnewswire.com
COYA | News | $8.54 1.19% 5.8K twitter stocktwits trandingview |
| | O: 0.0% H: 1.87% C: 0.5%
LLY | $731.1 -1.99% 1M twitter stocktwits trandingview |
Health Technology
 | | O: -0.06% H: 1.18% C: 0.37%
SEEL | $0.3375 -0.15% 88K twitter stocktwits trandingview |
Health Technology
 | | O: 1.48% H: 0.73% C: -2.19%
PRTA 4 | $20.74 0.83% 110K twitter stocktwits trandingview |
Health Technology
 | | O: 1.08% H: 2.08% C: 1.79%
PASG | $1.18 -1.67% 250K twitter stocktwits trandingview |
Health Technology
 | | O: 3.33% H: 0.0% C: -8.82%
IONS | $41.07 0.64% 140K twitter stocktwits trandingview |
Health Technology
 | | O: 0.33% H: 0.13% C: -1.56%
DNLI | $16.455 -0.87% 120K twitter stocktwits trandingview |
Health Technology
 | | O: 1.22% H: 0.0% C: -1.42%
SAVA | $20.48 -3.35% 250K twitter stocktwits trandingview |
Health Technology
 | | O: 0.6% H: 1.74% C: 1.24%
BIVI | News | $0.497 1.76% 240K twitter stocktwits trandingview |
Health Technology
 | | O: 0.43% H: 0.85% C: -2.12%
AXSM | $67.19 2.24% 200K twitter stocktwits trandingview |
Health Technology
 | | O: 0.56% H: 3.6% C: 0.99%
companies active dementia market
Arkuda Therapeutics to Present Update on ARKD-104, its First-in-Class Oral Development Candidate for the Treatment of Frontotemporal Dementia
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
LLY | $731.1 -1.99% 1M twitter stocktwits trandingview |
Health Technology
 | | O: -0.04% H: 1.43% C: 0.95%
arkd-104 candidate update treatment dementia therapeutics
Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Published: 2023-05-23 (Crawled : 12:00) - globenewswire.com
WVE | $4.86 1.25% 89K twitter stocktwits trandingview |
Health Technology
 | | O: -13.21% H: 27.02% C: 18.32%
wve-004 life sclerosis dementia sciences topline results study
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 510 twitter stocktwits trandingview |
Health Technology
 | | O: -4.57% H: 0.22% C: -1.98%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
 | | O: -1.46% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.0% C: 0.0%
VTRS | $11.2 0.72% 1M twitter stocktwits trandingview |
Health Technology
 | | O: 0.22% H: 0.65% C: -1.09%
NVS | $93.815 1.35% 410K twitter stocktwits trandingview |
Health Technology
 | | O: 0.62% H: 0.0% C: -2.04%
JNJ | News | $146.39 0.45% 1.8M twitter stocktwits trandingview |
Health Technology
 | | O: -0.66% H: 0.18% C: -0.9%
GSK | $39.685 1.06% 380K twitter stocktwits trandingview |
Health Technology
 | | O: -0.03% H: 0.3% C: -2.63%
SNY | News | $46.34 2.09% 620K twitter stocktwits trandingview |
Health Technology
 | | O: 0.53% H: 0.0% C: 0.0%
CNTG | $0.461 14K twitter stocktwits trandingview |
Commercial Services
 | | O: 1.23% H: 27.27% C: -15.76%
europe report dementia trials research growing market
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.98 36.55% 27M twitter stocktwits trandingview |
Commercial Services
CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
AULT | $0.304 25.57% 47M twitter stocktwits trandingview |
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.